Skip to main content
Access Resources

MJFF Publications

1226 - 1250 of 7461 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • OPEN
    Title: A biological classification of Huntington's disease: the Integrated Staging System
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00120-x
    Citation Count: 58
  • OPEN
    Title: Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases
    Journal Name: Progress in Neurobiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.pneurobio.2022.102270
    Citation Count: 60
  • RESTRICTED
    Title: An MDS Evidence‐Based Review on Treatments for Huntington's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29059
    Best OA location URL:
    Citation Count: 0
  • OPEN
    Title: Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.1166
    Citation Count: 27
  • OPEN
    Title: CD11b agonists offer a novel approach for treating lupus nephritis
    Journal Name: Translational Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.trsl.2022.03.001
    Citation Count: 7
  • OPEN
    Title: Clinical profiles and outcomes of deep brain stimulation in G2019S LRRK2 Parkinson disease
    Journal Name: Journal of Neurosurgery
    Publisher: Journal of Neurosurgery Publishing Group (JNSPG)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3171/2021.7.jns21190
    Citation Count: 2
  • RESTRICTED
    Title: Commentary on Long-term Effectiveness of Adjuvant Treatment in Parkinson Disease
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.1601
    Best OA location URL:
    Citation Count: 0
  • RESTRICTED
    Title: Commentary on Long-term Effectiveness of Adjuvant Treatment in Parkinson Disease—Reply
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.1604
    Best OA location URL:
    Citation Count: 0
  • OPEN
    Title: Convergence of signalling pathways in innate immune responses and genetic forms of Parkinson’s disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2022.105721
    Citation Count: 6
  • RESTRICTED
    Title: Deep learning architectures for Parkinson's disease detection by using multi-modal features
    Journal Name: Computers in Biology and Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.compbiomed.2022.105610
    Best OA location URL:
    Citation Count: 8
  • OPEN
    Title: Diabetes and Neuroaxonal Damage in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29067
    Citation Count: 5
  • RESTRICTED
    Title: Editor's Note
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29149
    Best OA location URL:
    Citation Count: 0
  • OPEN
    Title: European Academy of Neurology/Movement Disorder Society‐European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive Therapies
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29066
    Citation Count: 42
  • OPEN
    Title: Generation of homozygous PRKN, PINK1 and double PINK1/PRKN knockout cell lines from healthy induced pluripotent stem cells using CRISPR/Cas9 editing
    Journal Name: Stem Cell Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.scr.2022.102806
    Citation Count: 5
  • OPEN
    Title: Genetic Evidence Supporting a Causal Role of Depression in Alzheimer’s Disease
    Journal Name: Biological Psychiatry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.biopsych.2021.11.025
    Citation Count: 14
  • OPEN
    Title: Hierarchical Denoising of Ordinal Time Series of Clinical Scores
    Journal Name: IEEE Journal of Biomedical and Health Informatics
    Publisher: Institute of Electrical and Electronics Engineers (IEEE)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1109/jbhi.2022.3163126
    Citation Count: 4
  • RESTRICTED
    Title: ID:16203 Brachial Plexus Stimulation for Refractory Neuropathic Upper Limb Pain in a Traumatic Brain Injury Patient
    Journal Name: Neuromodulation: Technology at the Neural Interface
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurom.2022.02.011
    Best OA location URL:
    Citation Count: 0
  • RESTRICTED
    Title: ID:16220 Visualization Tool for DBS Programming Used With a Multiple-Source, Constant-Current System Reduces Initial Programming Time
    Journal Name: Neuromodulation: Technology at the Neural Interface
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurom.2022.02.012
    Best OA location URL:
    Citation Count: 0
  • RESTRICTED
    Title: Inconsistency and incongruence: the two diagnostic pillars of functional movement disorder
    Journal Name: The Lancet
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s0140-6736(22)01184-9
    Best OA location URL:
    Citation Count: 3
  • OPEN
    Title: Istradefylline for OFF Episodes in Parkinson’s Disease: A US Perspective of Common Clinical Scenarios
    Journal Name: Degenerative Neurological and Neuromuscular Disease
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.2147/dnnd.s245197
    Citation Count: 1
  • RESTRICTED
    Title: L-Dopa response, choreic dyskinesia, and dystonia in Perry syndrome
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.05.023
    Best OA location URL:
    Citation Count: 5
  • OPEN
    Title: Loss of tau expression attenuates neurodegeneration associated with α-synucleinopathy
    Journal Name: Translational Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s40035-022-00309-x
    Citation Count: 5
  • OPEN
    Title: LRRK2 as a target for modulating immune system responses
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2022.105724
    Citation Count: 9
  • OPEN
    Title: Newly Approved and Investigational Drugs for Motor Symptom Control in Parkinson's Disease
    Journal Name: Drugs
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s40265-022-01747-7
    Citation Count: 6
  • OPEN
    Title: Patient Experience in Early-Stage Parkinson’s Disease: Using a Mixed Methods Analysis to Identify Which Concepts Are Cardinal for Clinical Trial Outcome Assessment
    Journal Name: Neurology and Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1007/s40120-022-00375-3
    Citation Count: 6
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.